SYMBIVA 200MCG RHEOCAPS

SYMBIVA 200MCG RHEOCAPS is a respiratory medication primarily used to treat chronic obstructive pulmonary diseases (COPD) like bronchitis (inflammation of the lining of your bronchial tubes) and emphysema (shortness of breath). It may also be used to treat asthma. COPD is a group of lung diseases that causes obstructed airflow from the lungs.

SYMBIVA 200MCG RHEOCAPS contains Formoterol (bronchodilator) and Tiotropium (anticholinergic). SYMBIVA 200MCG RHEOCAPS works by relaxing the muscles in the airways, thereby improving breathing and reducing symptoms such as wheezing, coughing, and shortness of breath.

The common side effects of SYMBIVA 200MCG RHEOCAPS include headache, dizziness, dry mouth, nausea, sore throat, and hoarseness. Most of these side effects of SYMBIVA 200MCG RHEOCAPS do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Do not use SYMBIVA 200MCG RHEOCAPS to treat sudden severe symptoms or as a rescue inhaler. Please check with your doctor if you are pregnant, breastfeeding, or taking other prescribed or non-prescribed medicines. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.

SYMBIVA 200MCG RHEOCAPS is used in the treatment of chronic Obstructive Pulmonary Disease (COPD), including bronchitis and emphysema. The detailed uses of SYMBIVA 200MCG RHEOCAPS are as follows:

• COPD treatment: SYMBIVA 200MCG RHEOCAPS is highly effective in managing chronic obstructive pulmonary disease (COPD), a progressive lung condition. It helps alleviate symptoms such as breathlessness and wheezing, thereby ensuring better respiratory function.
• Inflammation control: SYMBIVA 200MCG RHEOCAPS is effective in reducing swelling in the airways, which makes it easier for individuals with respiratory conditions to breathe.

• Recommended to take SYMBIVA 200MCG RHEOCAPS twice a day or as advised by your doctor.
• Shake the inhaler well and check the label for directions before using.. Hold it upright and place the mouthpiece between your teeth without biting it. Breathe in slowly through your mouth and press the top of the inhaler at the same time to release the medicine.
• Remove the inhaler and hold your breath for a few seconds, then breathe out slowly.
• Rinse your mouth with water and spit it out after using it to avoid fungal infections in the mouth and throat.

SYMBIVA 200MCG RHEOCAPS is a respiratory medication primarily used to treat chronic obstructive pulmonary diseases (COPD) like bronchitis (inflammation of the lining of your bronchial tubes) and emphysema (shortness of breath). It may also be used to treat asthma. SYMBIVA 200MCG RHEOCAPS contains Formoterol (bronchodilator) and Tiotropium (anticholinergic). SYMBIVA 200MCG RHEOCAPS works by relaxing the muscles in the airways, thereby improving breathing and reducing symptoms such as wheezing, coughing, and shortness of breath.

Do not use SYMBIVA 200MCG RHEOCAPS if you are allergic to any of its components. Inform the doctor if you have heart, liver, or kidney diseases, high blood pressure, hypokalaemia (low potassium levels in the blood), aneurysm (swelling of an artery), pheochromocytoma (adrenal gland tumour), hyperadrenocorticism (high levels of cortisol), eye disorders like cataract and glaucoma, chickenpox or measles, immune system problem, seizure (fits), osteoporosis (weak and brittle bones) or diabetes. Special precautions should be taken in patients with a fungal, bacterial, parasitic, or viral infection and tuberculosis since nasal or inhaled corticosteroids can cause secondary infections. SYMBIVA 200MCG RHEOCAPS can cause a rise in blood glucose levels. Hence, monitor your blood glucose levels regularly and inform your doctor if you already have diabetes before using SYMBIVA 200MCG RHEOCAPS. SYMBIVA 200MCG RHEOCAPS may affect the unborn baby during pregnancy. Please let your doctor know if you plan to become pregnant or are already pregnant or if you are a lactating mother. SYMBIVA 200MCG RHEOCAPS is not recommended for children below five years of age.